drugset / Trial / NCT04475887
Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in patients with IDA listed for OLT.
Timeline
- Start
- 2020-07-23
- Primary completion
- 2022-12-31
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric carboxymaltose | Other / unclassified | — | Intravenous |
Indications
No indication recorded.